U-Blot® Research Grade RevdofilimabCat. No. WA3448Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RevdofilimabCat. No. WA3448
U-Blot® Research Grade revbekitugCat. No. WA3447
U-Blot® Research Grade Retlirafusp AlfaCat. No. WA3446
U-Blot® Research Grade RetifanlimabCat. No. WA3445
U-Blot® Research Grade retavibartCat. No. WA3444
U-Blot® Research Grade RetatrutideCat. No. WA3443
U-Blot® Research Grade ResugosbartCat. No. WA3442
U-Blot® Research Grade ReslizumabCat. No. WA3441
U-Blot® Research Grade ReozalimabCat. No. WA3440
U-Blot® Research Grade RenvistobartCat. No. WA3439
U-Blot® Research Grade renditatugCat. No. WA3438
U-Blot® Research Grade remzistotugCat. No. WA3437